HIV-1 MN #1963 is a short fragment used to investigate fine variations in gp120's surface architecture. Its sequence supports evaluation of charged and hydrophobic clustering. Researchers examine motif positioning to delineate interaction determinants. The peptide enriches MN-strain structural studies.
CAT No: H09774
1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More